Evidence map›Paper›PMID 42101989›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

How endosomal PIKfyve inhibition prevents viral membrane fusion and entry.

Nicholas Chow, Gustavo Scanavachi, Anand Saminathan, Tom Kirchhausen

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Nicholas Chow *Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0002-9923-3044
Gustavo Scanavachi *Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0002-4001-3389
Anand Saminathan *Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.
Tom KirchhausenProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0003-0559-893X

Funding

VISUALIZATION OF SUBCELLULAR DYNAMICS IN MULTICELLULAR ORGANISMSR35GM130386 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI TOMAS KIRCHHAUSEN · 2019 to 2026
$4.0M
Mechanism and Inhibition of SARS-CoV-2 EntryR01AI163019 · NIAID · WASHINGTON UNIVERSITY · PI KIRCHHAUSEN, TOMAS, WHELAN, SEAN PJ · 2021 to 2025
$3.8M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI163019-05HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM130386NIAID NIH HHS R01 AI163019NIGMS NIH HHS R35 GM130386
6 · The paper itself

Abstract

Enveloped viruses enter cells by membrane fusion. The viral membrane fuses with a host membrane, either at the cell surface or within endocytic compartments. For endocytic entry, fusion is typically triggered by low pH and often requires proteolytic priming by compartment-specific host proteases, which together define the site and mechanism of fusion and shape viral tropism. Inhibition of the lipid kinase PIKfyve, which generates PI(5)P and PI(3,5)P

Indexed as

EndosomesMembrane FusionPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsVirus InternalizationAnimalsHumansLysosomesSARS-CoV-2Phosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPIKFYVE protein, humanendosomal fusionlattice light-sheet microscopymembrane tensionPIKfyve inhibitionviral entry

Identifiers

PMID42101989
PMCPMC13167751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.